Amapola Manrique
 | Bio: | Dr. Amapola Manrique is a Science Officer at the Global HIV Vaccine Enterprise (the Enterprise). In this role, Dr. Manrique is responsible for implementing the vision of the Enterprise through identification, development, and management of initiatives that support the Scientific Strategic Plan for HIV vaccine research and development. Dr. Manrique also directs the scientific program for the annual AIDS Vaccine conference, the largest and most important global scientific conference focused on AIDS vaccine research. She also leads the Enterprise’s New Minds, New Ideas initiative developing strategies and managing programs that will help establish a culture and infrastructures that enable Young and Early Career Investigators (YECI) to develop and to explore new ideas in the HIV vaccine field. Currently Dr. Manrique is overseeing a capacity-building series of online and face-to-face workshops with the OCTAVE Project (Online Collaborative Training for AIDS Vaccine Evaluation) to help engage, educate and train more than 100 YECIs from low and middle income countries.
Prior to joining the Enterprise Secretariat, Dr. Manrique was the Scientific Assistant to the AIDS Vaccine 2008 conference in South Africa, which brought together approximately 1,000 scientists, community advocates, funders, and policy makers from around the world.
Dr. Manrique has studied HIV for more than 10 years. She completed her doctoral training with Prof. Dr. A. Trkola and Prof. Dr. S. Bonhoeffer at the Swiss Federal Institute of Technology, ETH Zurich, Switzerland.
Dr. Manrique holds a masters degree in molecular biology from the University of Fribourg in Switzerland and a Ph.D. in biology from the Swiss Federal Institute of Technology.
|  |
 | e-mail: | amanrique@vaccineenterprise.org | |
 | Address: | Global HIV Vaccine Enterprise
200 Park Ave. South, Ste 1501
US - United States | |
Last update: Thursday, May 5, 2011
|